Ashland Inc. · NYSE:ASH

Ashland — Q4 2020 Earnings Presentation

39 slides from Ashland's earnings presentation, Nov 11, 2020

  1. Slide 1: Earnings Conference Call Fourth-Quarter Fiscal 2020

    Earnings Conference Call Fourth-Quarter Fiscal 2020 November 11, 2020 – 9:00am Eastern Time / efficacy usability allure integrity profitability

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words

  3. Slide 3: Agenda

    agenda o Q4 performance summary o Q4 & FY financial results o priorities and outlook o closing comments o thank you and Q&A 3

  4. Slide 4: Q4 performance summary

    Q4 performance summary «<f Ashland always solving

  5. Slide 5: Our Priorities in Current Environment

    Ashland Global Holdings Inc. Our Priorities in Current Environment priority # 1 contingency planning for COVID-19 uncertainty o health and safety of our employees o continued supply to our customers and the critical industries we serve priority # 2 execute on our strategy o margin expansion o enhanc

  6. Slide 6: Commentary on Q4 Performance

    Ashland Global Holdings Inc. Commentary on Q4 Performance o resilient consumer end-market demand o significant sequential improvement in global industrial demand o favorable price/mix and adjusted operating costs o continued benefit from cost-reduction program leading to expanded margins o free cash

  7. Slide 7: Q4 & FY financial results

    Q4 & FY financial results «<f Ashland always solving

  8. Slide 8: Fiscal-Fourth Quarter Adjusted Results

    Ashland Global Holdings Inc. Fiscal-Fourth Quarter Adjusted Results1 ($US in millions, except percentages) Q4 FY20 Q4 FY19 Change Sales $609 $609 - Gross profit margin 34.3 % 34.4 % (10) bps SG&A / R&D costs / Intangible amortization $118 $124 (5) % Operating Income (EBIT) $91 $85 +7 % EBITDA $154 $

  9. Slide 9: Consumer Specialties Adjusted Results Summary

    Consumer Specialties Adjusted Results Summary1 ($US in millions, except percentages) Q4 FY20 Q4 FY19 Change Sales $344 $332 +4 % Gross profit $127 $121 +5 % Gross profit margin 36.9 % 36.4 % +50 bps Operating Income (EBIT) $62 $53 +17 % EBITDA $97 $88 +10 % EBITDA margin 28.2 % 26.5 % +170 bps o res

  10. Slide 10: Industrial Specialties Adjusted Results Summary

    Industrial Specialties Adjusted Results Summary1 ($US in millions, except percentages) Q4 FY20 Q4 FY19 Change Sales $240 $247 (3) % Gross profit $76 $76 - Gross profit margin 31.7 % 30.8 % +90 bps Operating Income (EBIT) $39 $37 +5 % EBITDA $64 $62 +3 % EBITDA margin 26.7 % 25.1 % +160 bps o industr

  11. Slide 11: Intermediates & Solvents Adjusted Results Summary

    Intermediates & Solvents (I&S) Adjusted Results Summary1 ($US in millions, except percentages) Q4 FY20 Q4 FY19 Change Sales $28 $42 (33) % Gross profit $5 $12 (58) % Gross profit margin 17.9 % 28.6 % (1,070) bps Operating Income (EBIT) $3 $9 (67) % EBITDA $6 $13 (54) % EBITDA margin 21.4 % 31.0 % (9

  12. Slide 12: Inventory Control / Free Cash Flow

    Ashland Global Holdings Inc. Inventory Control / Free Cash Flow o exceeded original targets for inventory-control actions o reduced inventory by $99 million compared to June-quarter end; balance offset by $11 million FX impact on remaining inventory o generated $116 million of free cash flow in Q4,

  13. Slide 13: Fiscal Year 2020 Summary

    Ashland Global Holdings Inc. Fiscal Year 2020 Summary1 ($US in millions, except percentages and FY20 FY19 Change per share data) Consumer Specialties $1,323 $1,383 (4) % Industrial Specialties $899 $999 (10) % Intermediates & Solvents $129 $160 (19) % Photo Intersegment Sales ($25) ($49) +49 % Sales

  14. Slide 14: Priorities and outlook

    oriorities and outlook «<f Ashland always solving

  15. Slide 15: Our Priorities

    Ashland Global Holdings Inc. Our Priorities margin expansion business resilience o 2020 SARD reduction o business unit focus o S&OP discipline (increase BU o 2021 COGS/SARD reduction operating visibility) o innovation and mix o organizational ownership / improvement accountability o exit low-end pro

  16. Slide 16: Outlook

    Ashland Global Holdings Inc. Outlook not providing specific FY2021 guidance given macro uncertainty forward-looking insights FY2020 performance o assume current continued recovery in + sales growth global demand, 2 – 4% sales growth in fiscal 2021 o incremental volume growth comes at + cost reductio

  17. Slide 17: Strategic Focus

    Ashland Global Holdings Inc. Strategic Focus o expand additives portfolio o build out bio-tech capabilities o accelerate our growth in Asia o customer-focused & innovation-centric culture o accelerate our digital modernization 17

  18. Slide 18: CEO Priorities

    Ashland Global Holdings Inc. CEO Priorities complete the transformation o operational performance of our business model o deliver $100 MM cost reductions and margin expansion o disciplined capital allocation aligned with strategy focus on growth o commercial excellence & geographic growth o customer

  19. Slide 19: Closing comments

    closing comments «<f Ashland always solving

  20. Slide 20: Premier Specialty Materials Company

    Ashland Global Holdings Inc. Premier Specialty Materials Company o focused on high-quality markets and businesses with exciting profitable growth opportunities o franchise businesses have leadership positions • #1 or #2 • strong teams with deep industry expertise • excellent customer relationships a

  21. Slide 21: Thank you and Q&A

    thank you and Q&A of Ashland

  22. Slide 22: Appendix A: Adjusted Results Summary and Balance Sheet

    Appendix A: Adjusted Results Summary and Balance Sheet

  23. Slide 23: Adjusted Results Summary

    Ashland Global Holdings Inc. Adjusted Results Summary1 ($US in millions, except percentages and Q4 FY20 Q4 FY19 Change per share data) Sales $609 $609 - Gross profit $209 $210 (1) % Gross profit margin 34.3 % 34.4 % (10) bps Photo SG&A / R&D costs / Intangible amort. $118 $124 (5) % Operating income

  24. Slide 24: Q4 Business Unit Consolidation

    Ashland Global Holdings Inc. Q4 Business Unit Consolidation ($US in millions, except Consumer Industrial Interco Unallocated I&S Ashland percentages) Specialties Specialties Eliminations and Other Sales $344 $240 $28 ($3) - $609 Gross profit $127 $76 $5 - - $209 Gross profit margin 36.9 % 31.9 % 17.

  25. Slide 25: Liquidity and Net Debt

    Ashland Global Holdings Inc. Liquidity and Net Debt Interest Moody’s 9/30/20 ($US in millions) Expiration S&P Rating Rate Rating Balance Cash $454 Revolver and A/R facility availability 500 Cash, A/R and revolver availability $954 Photo Debt 2.00% Notes (EUR) Jan. 2028 2.000% Ba1 BB+ $587 4.750% Not

  26. Slide 26: Appendix B: Non-GAAP Reconciliation

    Appendix B: Non-GAAP Reconciliation1 1 Although Ashland provides forward looking guidance for adjusted EBITDA in this presentation, Ashland is not reaffirming or providing forward-looking guidance for U.S. GAAP reported financial measures or a reconciliation of forward-looking non-GAAP financial mea

  27. Slide 27: Reconciliation of Non-GAAP Data

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Reconciliation of Non-GAAP Data for 12 Months Ended September 30, 2020 ($ millions, except percentages) 1 Sales Q4 20 Q3 20 Q2 20 Q1 20 Total Q4 19 Life Sciences $ 180 $ 189 $ 184 $ 155 $ 708 $ 176 Personal Care & Household 164 155 159 137 6

  28. Slide 28: Segment Components of Key Items for Income Statement Captions (Q4 2020)

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Segment Components of Key Items for Applicable Income Statement Captions for 3 Months Ended September 30, 2020 ($ millions) Three Months Ended September 30, 2020 Life Personal Care Consumer Specialty Performance Industrial Intermediates Unal

  29. Slide 29: Segment Components of Key Items for Income Statement Captions (Q4 2019)

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Segment Components of Key Items for Applicable Income Statement Captions for 3 Months Ended September 30, 2019 ($ millions) Three Months Ended September 30, 2019 Life Personal Care Consumer Specialty Performance Industrial Intermediates Unal

  30. Slide 30: Free Cash Flow and Adjusted Operating Income (3 Months)

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Reconciliation of Non-GAAP Data – Free Cash Flow and Adjusted Operating Income for 3 Months Ended September 30, 2020 and 2019 ($ millions) Three months ended September 30 1 Free cash flows 2020 2019 Total cash flows provided by operating act

  31. Slide 31: Free Cash Flow and Adjusted Operating Income (12 Months)

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Reconciliation of Non-GAAP Data – Free Cash Flow and Adjusted Operating Income for 12 Months Ended September 30, 2020 and 2019 ($ millions) Year Ended September 30 1 Free cash flows 2020 2019 Total cash flows provided by operating activities

  32. Slide 32: Reconciliation of Non-GAAP Data – Adjusted EBITDA

    Ashland Global Holdings Inc. Reconciliation of Non-GAAP Data – Adjusted EBITDA for 3 Months Ended September 30, 2020 and 2019 ($ millions) Three months ended September 30 Adjusted EBITDA - Ashland Global Holdings Inc. 2020 2019 Net income (loss) $ 5 $ 411 Income tax expense (benefit) 9 22 Net intere

  33. Slide 33: Adjusted EBITDA – Consumer Specialties

    Consumer Specialties Reconciliation of Non-GAAP Data – Adjusted EBITDA for 3 Months Ended September 30, 2020 and 2019 ($ millions) Three months ended September 30 2020 2019 Life Sciences Operating income $ 26 $ 26 Add: Depreciation and amortization 15 15 Operating key items (see pages 28 & 29) 10 -

  34. Slide 34: Adjusted EBITDA – Industrial Specialties, Intermediates and Solvents

    Industrial Specialties, Intermediates and Solvents Reconciliation of Non-GAAP Data – Adjusted EBITDA for 3 Months Ended September 30, 2020 and 2019 Three months ended ($ millions) September 30 2020 2019 Specialty Additives Operating income $ 5 $ 22 Add: Depreciation and amortization 21 21 Operating

  35. Slide 35: Adjusted Income from Continuing Operations (3 Months)

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Reconciliation of Non-GAAP Data – Adjusted Income from Continuing Operations for 3 Months Ended September 30, 2020 and 2019 Three months ended September 30 ($ millions) 2020 2019 Income (loss) from continuing operations (as reported) $ - $ 2

  36. Slide 36: Adjusted Income from Continuing Operations (Year)

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Reconciliation of Non-GAAP Data – Adjusted Income from Continuing Operations for year ended September 30, 2020 and 2019 Year Ended September 30 ($ millions) 2020 2019 Income (loss) from continuing operations (as reported) $ (491) $ 24 Key it

  37. Slide 37: Adjusted Diluted EPS from Continuing Operations (3 Months)

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Reconciliation of Non-GAAP Data – Adjusted Diluted EPS from Continuing Operations for 3 Months Ended September 30, 2020 and 2019 Three months ended September 30 ($ millions) 2020 2019 Diluted EPS from continuing operations (as reported) $ -

  38. Slide 38: Adjusted Diluted EPS from Continuing Operations (Year)

    Ashland Global Holdings Inc. and Consolidated Subsidiaries Reconciliation of Non-GAAP Data – Adjusted Diluted EPS from Continuing Operations for year ended September 30, 2020 and 2019 Year Ended September 30 ($ millions) 2020 2019 Diluted EPS from continuing operations (as reported) $ (8.10) $ 0.39

  39. Slide 39: Trademark notice

    ® Registered trademark, Ashland or its subsidiaries, registered in various countries ™ Trademark, Ashland or its subsidiaries, registered in various countries

Ashland — Q4 2020 Earnings Presentation on 6ix